Price
Financials
Consolidated, Rs crore| Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Expenses | 0.06 | 0.05 | 0.07 | 0.06 | 0.09 | 0.28 | 0.20 | 0.13 | 0.26 | 0.07 | 0.21 | 0.17 |
| Operating Profit | -0.06 | -0.05 | -0.07 | -0.06 | -0.09 | -0.28 | -0.20 | -0.13 | -0.26 | -0.07 | -0.21 | -0.17 |
| OPM % | ||||||||||||
| Other Income | 0.07 | 0.02 | 0.02 | 0.05 | 0.06 | 0.03 | 0.45 | 0.46 | 0.55 | 0.42 | 0.44 | 0.42 |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.01 |
| Depreciation | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.02 | 0.02 | 0.02 | 0.01 | 0.15 | 0.03 | 0.03 |
| Profit before tax | 0.01 | -0.03 | -0.05 | -0.01 | -0.03 | -0.27 | 0.23 | 0.31 | 0.28 | 0.20 | 0.20 | 0.21 |
| Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 47.83% | -0.00% | -0.00% | -15.00% | -0.00% | -0.00% |
| Net Profit | -0.00 | -0.03 | -0.05 | -0.01 | -0.03 | -0.26 | 0.11 | 0.31 | 0.27 | 0.23 | 0.20 | 0.22 |
| EPS in Rs | -0.00 | -0.19 | -0.31 | -0.06 | -0.19 | -0.73 | 0.31 | 0.87 | 0.76 | 0.64 | 0.13 | 0.14 |
| Mar 2022 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| Sales | 1.16 | 1.49 | -0.00 | 0.00 |
| Expenses | 1.11 | 1.87 | 0.68 | 0.71 |
| Operating Profit | 0.05 | -0.38 | -0.68 | -0.71 |
| OPM % | 4.31% | -25.50% | ||
| Other Income | 0.27 | 0.64 | 1.87 | 1.83 |
| Interest | -0.00 | 0.01 | -0.00 | 0.01 |
| Depreciation | -0.00 | 0.04 | 0.21 | 0.22 |
| Profit before tax | 0.32 | 0.21 | 0.98 | 0.89 |
| Tax % | -21.88% | 52.38% | -3.06% | |
| Net Profit | 0.39 | 0.09 | 1.00 | 0.92 |
| EPS in Rs | 2.44 | 0.25 | 0.63 | 1.67 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | -100% | ||
| Compounded Profit Growth | % | % | % | 1150% | ||
| Stock Price CAGR | 25% | 52% | 29% | -61% | ||
| Return on Equity | % | % | % | 1% |
| Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 0.36 | 0.36 | |
| Reserves | 138.99 | 139.61 | |
| Borrowings | -0.00 | -0.00 | |
| Other Liabilities | 0.15 | 1.34 | |
| Total Liabilities | 139.50 | 141.31 | |
| Fixed Assets | 0.50 | 0.31 | |
| CWIP | 118.96 | 120.17 | |
| Investments | -0.00 | -0.00 | |
| Other Assets | 20.04 | 20.83 | |
| Total Assets | 139.50 | 141.31 |
| Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from Operating Activity | 0.91 | 31.05 | -0.69 |
| Cash from Investing Activity | 0.19 | -116.66 | 0.48 |
| Cash from Financing Activity | -0.00 | 100.39 | -0.04 |
| Net Cash Flow | 1.10 | 14.78 | -0.25 |
| Free Cash Flow | 0.91 | -88.44 | -1.92 |
| CFO/OP | 1,780% | -8,171% | 97% |
| Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 4.90 | ||
| Inventory Days | -0.00 | -0.00 | |
| Days Payable | |||
| Cash Conversion Cycle | 4.90 | ||
| Working Capital Days | 161.68 | ||
| ROCE % | 0.70% |
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 61.43% | 61.43% | 60.96% | 60.96% | 60.96% | 60.96% | 60.96% | 60.96% | 60.96% | 61.00% | 61.00% | 61.00% |
| DIIs | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% |
| Public | 38.51% | 38.51% | 38.98% | 38.98% | 38.98% | 38.97% | 38.97% | 38.98% | 38.97% | 38.93% | 38.94% | 38.94% |
| No. of Shareholders | 5,356 | 5,295 | 5,301 | 5,230 | 5,277 | 5,351 | 5,399 | 5,385 | 5,319 | 5,306 | 5,326 | 5,374 |
Fundamentals
Market Cap₹ 209 Cr.
Current Price₹ 131
Stock P/E227
Book Value₹ 87.9
ROCE0.70 %
ROE0.72 %
Dividend Yield0.08 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)-100%
Compounded Profit Growth (TTM)1150%
Consolidated figures.
Ownership
Promoter holding61.00% (+0.04 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | 506640 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -0.3% | -2.8% | +2.5 pts |
| 1 month | +21.5% | -6.8% | +28.3 pts |
| 3 months | +11.7% | -7.6% | +19.3 pts |
| 3 years | +120.5% | +14.2% | +106.3 pts |
| 5 years | +742.1% | +27.9% | +714.2 pts |
Red flags
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr.
Net profit ₹0 Cr -29.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| SRF Ltd | 71,738 | 32.0 | 14.6 % |
| Deepak Fertilisers & Petrochemicals Corp Ltd | 16,523 | 16.8 | 11.4 % |
| Tata Chemicals Ltd | 15,638 | 3.42 % | |
| Gujarat Narmada Valley Fertilizers & Chemicals Ltd | 8,985 | 8.66 | 12.0 % |
| Tanfac Industries Ltd | 7,226 | 107 | 23.9 % |
| Gujarat Alkalies & Chemicals Ltd | 4,606 | 69.4 | 1.42 % |
| Grauer & Weil (India) Ltd | 3,744 | 23.4 | 20.6 % |
| GHCL Ltd | 3,724 | 8.16 | 17.4 % |
| J.G.Chemicals Ltd | 2,576 | 34.3 | 18.1 % |
| Thirumalai Chemicals Ltd | 1,834 | -3.15 % | |
| I G Petrochemicals Ltd | 1,801 | 22.1 | 3.11 % |
| Indo Borax & Chemicals Ltd | 1,569 | 32.0 | 15.4 % |
| Innovassynth Technologies (India) Ltd | 1,405 | -16.4 % | |
| Citurgia Biochemicals Ltd | 1,380 | % | |
| Vikram Thermo (India) Ltd | 1,320 | 30.1 | 36.2 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of ZR2 Bioenergy Ltd?
ZR2 Bioenergy Ltd (506640) has a market capitalisation of Rs 209 Cr. at the 2026-10-01 close.
What is the P/E ratio of ZR2 Bioenergy Ltd?
ZR2 Bioenergy Ltd trades at a P/E of 227 on trailing twelve-month profit, at the 2026-10-01 close.
What were ZR2 Bioenergy Ltd's latest quarterly results?
In the Jun 2026 quarter, ZR2 Bioenergy Ltd sales was Rs 0 Cr and net profit was Rs 0 Cr.